The RNA Therapeutics industry is experiencing unprecedented momentum driven by innovations in RNA technology platforms and expanding clinical applications in treating genetic disorders and infectious diseases. This market’s evolution reflects rapid scientific breakthroughs combined with heightened interest from biopharma sectors to harness RNA modalities for personalized medicine.


Market Size and Overview
The RNA Therapeutics Market is estimated to be valued at USD 4.2 Mn in 2026 and is expected to reach USD 160.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 68.2% from 2026 to 2033.

This market forecast underscores significant business growth fueled by advances in delivery systems and growing adoption of RNA-based treatments globally. The increasing pipeline of RNA vaccines and therapeutics addressing unmet medical needs has considerably expanded the market scope in recent years, reflecting bright RNA Therapeutics Market Opportunities and evolving market dynamics.

Market Segments
The RNA Therapeutics market comprises three core segments:
- Product Type: Sub-segments include mRNA therapeutics, siRNA therapeutics, and antisense RNA. The mRNA therapeutic segment dominates revenue contribution due to successful products like mRNA vaccines approved in 2024, while siRNA shows the fastest growth supported by clinical trial advancements.
- Application: Encompasses oncology, infectious diseases, and genetic disorders. Oncology leads as the dominant segment with major investments from market companies in immunotherapies, whereas infectious diseases are rapidly progressing propelled by recent vaccine developments in 2024 and 2025.
- End User: Hospitals, research institutes, and pharmaceutical companies. Hospitals remain the key end user for RNA therapeutics delivery, but pharmaceutical companies demonstrate the fastest expansion driven by increasing R&D pipelines focused on RNA therapeutics.

‣ Get more insights on : RNA Therapeutics Market

‣ Get this Report in Japanese Language:  RNA治療薬市場

‣ Get this Report in Korean Language:   RNA치료제시장